1887
  1. Home
  2. Eurosurveillance
  3. Volume 30, Issue 45, 13/Nov/2025
  4. Article
Outbreaks Open Access
Like 0
Download

SDG 3: Antimicrobial resistance

Abstract

We describe the emergence of vancomycin-resistant (VREfm) ST612 in Switzerland from 2018 to 2024 that resulted in a national outbreak investigation. This clone has predisposing genetic alterations associated with reduced daptomycin susceptibility. The National Nosocomial Outbreak Investigation Center was commissioned to assess the temporospatial distribution of this clone in Switzerland and evaluate its clinical impact. Core genome multi-locus sequence typing (cgMLST) revealed five separate VREfm A ST612 clusters of different sizes across different healthcare regions, but predominantly in the German-speaking part. The broad geographic dissemination and temporal variation in detection suggests multiple introductions to the healthcare system. One of these cgMLST clusters (n = 79 cases) with an infection rate of 12.8% was ongoing, mainly affecting patients with extensive contact to the Swiss healthcare system or prior antibiotic exposure. The detection of daptomycin non-susceptibility in patients without prior daptomycin exposure suggests ongoing adaptation due to external pressures. Future prevention efforts should emphasise assessing barriers for active surveillance cultures, developing a national standard for cost-effective sequencing methods and promoting the sharing of sequencing results together with epidemiological metadata. Our report intends to raise awareness as this sequence type might already be spreading undetected in European countries.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.45.2500227
2025-11-13
2026-04-20
/content/10.2807/1560-7917.ES.2025.30.45.2500227
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/45/eurosurv-30-45-3.html?itemId=/content/10.2807/1560-7917.ES.2025.30.45.2500227&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). WHO bacterial priority pathogens list, 2024. Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO; 2024. Available from: https://www.who.int/publications/i/item/9789240093461
  2. Frakking FNJ, Bril WS, Sinnige JC, Klooster JEV, de Jong BAW, van Hannen EJ, et al. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting. J Hosp Infect. 2018;100(4):e216-25.  https://doi.org/10.1016/j.jhin.2018.02.016  PMID: 29475013 
  3. Liese J, Schüle L, Oberhettinger P, Tschörner L, Nguyen T, Dörfel D, et al. Expansion of vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole-genome-based outbreak investigation. Antimicrob Agents Chemother. 2019;63(5):e01978-18.  https://doi.org/10.1128/AAC.01978-18  PMID: 30782988 
  4. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/healthcare-associated-point-prevalence-survey-acute-care-hospitals-2022-2023.pdf
  5. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals, 2016-2017. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/healthcare-associated--infections-antimicrobial-use-point-prevalence-survey-2016-2017.pdf
  6. Federal Office of Public health, Federal Food Safety and Veterinary Office and Strategy on Antimicrobial Resistance. (StAR). Swiss Antibiotic Resistance Report 2024. Usage of Antibiotics and Occurrence of Antibiotic Resistance in Switzerland]. Bern: StAR; 2024. Available from: https://www.star.admin.ch/de/sarr
  7. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710-21.  https://doi.org/10.1056/NEJM200003093421007  PMID: 10706902 
  8. Pruis I, Sandijck A, Burggraaf A, Smit P, Stel JVD, Damen M. VRE Screening Program and costs of three VRE outbreaks 2021, 2015 and 2018 (Abstracts from the 5th International Conference on Prevention & Infection Control (ICPIC 2019)). Antimicrob Resist Infect Control. 2019;8(S1).
  9. Kavanagh NL, Kinnevey PM, Egan SA, McManus BA, O’Connell B, Brennan GI, et al. Protracted transmission and persistence of ST80 vancomycin-resistant Enterococcus faecium clonal complex types CT2933, CT2932 and CT1916 in a large Irish hospital: a 39-month WGS study. J Hosp Infect. 2024; (151):11-0.  https://doi.org/10.1016/j.jhin.2024.06.002  PMID: 38944282 
  10. Egan SA, Kavanagh NL, Shore AC, Mollerup S, Samaniego Castruita JA, O’Connell B, et al. Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland. J Antimicrob Chemother. 2022;77(2):320-30.  https://doi.org/10.1093/jac/dkab393  PMID: 34747439 
  11. Gideskog M, Welander J, Hällgren A. Outbreak of vancomycin-resistant Enterococcus faecium starting among patients admitted to a surgical unit in a Swedish county. ResearchSquare; 2022.
  12. Zouari A, Nogues S, Collet A, Lecourt M, Guérin F, Cattoir V. Charactéristiques et évolution des souches cliniques d’entérococoques résistantes à la vancomycine et/ou au linézolide isolées en France, 2006-2022. [Characteristics and evolution of clinical vancomycin and/or linezolid resistant Enterococcus strains in France, 2006-2022]. Paris: Santé publique France; 2023. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-associees-aux-soins-et-resistance-aux-antibiotiques/resistance-aux-antibiotiques/documents/article/caracteristiques-et-evolution-des-souches-cliniques-d-enterocoques-resistantes-a-la-vancomycine-et-ou-au-linezolide-isolees-en-france-2006-2022
  13. Cheah ALY, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181-9.  https://doi.org/10.1111/1469-0691.12132  PMID: 23398607 
  14. Turnidge J, Kahlmeter G, Cantón R, MacGowan A, Giske CG, European Committee on Antimicrobial Susceptibility Testing. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. Clin Microbiol Infect. 2020;26(8):1039-43.  https://doi.org/10.1016/j.cmi.2020.04.027  PMID: 32353412 
  15. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, Version 14.0, 2024. Växjö: EUCAST. [Accessed: 20 Dec 2024]. Available from: https://www.eucast.org/clinical_breakpoints
  16. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.  https://doi.org/10.1016/j.jbi.2019.103208  PMID: 31078660 
  17. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-81.  https://doi.org/10.1016/j.jbi.2008.08.010  PMID: 18929686 
  18. de Been M, Pinholt M, Top J, Bletz S, Mellmann A, van Schaik W, et al. Core genome multilocus sequence typing scheme for high-resolution typing of enterococcus faecium. J Clin Microbiol. 2015;53(12):3788-97.  https://doi.org/10.1128/JCM.01946-15  PMID: 26400782 
  19. Florensa AF, Kaas RS, Clausen PTLC, Aytan-Aktug D, Aarestrup FM. ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb Genom. 2022;8(1):000748. . https://doi.org/10.1099/mgen.0.000748  PMID: 35072601 
  20. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med. 2011;365(10):892-900.  https://doi.org/10.1056/NEJMoa1011138  PMID: 21899450 
  21. Coll F, Gouliouris T, Blane B, Yeats CA, Raven KE, Ludden C, et al. Antibiotic resistance determination using Enterococcus faecium whole-genome sequences: a diagnostic accuracy study using genotypic and phenotypic data. Lancet Microbe. 2024;5(2):e151-63.  https://doi.org/10.1016/S2666-5247(23)00297-5  PMID: 38219758 
  22. Vuichard-Gysin D, Senn L, Tschudin-Sutter S, Kuster S, Buetti N, Eder M, et al. Prävention und Kontrolle von multiresistenten Erregern (MRE) im Nicht-Ausbruch-Setting. [Prevention and control of multidrug-resistant organisms in the non-epidemic setting]. Bern: Swissnoso; 2021. German. Available from: https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/8_Swissnoso_Publikationen/211115_StAR_Teil_II_DE_MDRO-non-outbreak_FINAL.pdf
  23. Senn L, Vuichard-Gysin D, National Nosocomial Outbreak Investigation Center Swissnoso. Information und Massnahmen bezüglich des Aufkommens und der raschen interregionalen Verbreitung von Vancomycin-resistenten Enterococcus faecium (VRE) vanA ST612 in der Schweiz. [Information and measures concercning the emergence and rapid interregional spread of vancomycin-resistant Enterococcus faecium (VRE) vanA ST612 in Switzerland]. Bern: Swissnoso; 2024. German. Available from: https://swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Ereignisse/240216_Swissnoso_alert_VRE_vanA_ST612_DE.pdf
  24. Vuichard-Gysin D, Buetti N, Tschudin-Sutter S, Senn L, Kuster S, Metsini A, et al. Management von Ausbrüchen mit multiresistenten Erregern. [Management of outbreaks with multidrug-resistant organisms]. Bern: Swissnoso; 2021. German. Available from: https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/8_Swissnoso_Publikationen/211015_StAR_Teil_III_DE_MDRO_Outbreak_fin.pdf
  25. Vuichard-Gysin D, Buetti N, Kuster S, Tschudin-Sutter S. Laurence AW for Swissnoso. Erkennung, Untersuchung und Management von Healthcare-assoziierten Ausbrüchen in Akutspitälern und Rehabilitationskliniken. [Detection, investigation and management of healthcare-associated outbreaks in acute care hospitals and rehabilitation clinics] Bern: Swissnoso; 2021. German. Available from: https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/8_Swissnoso_Publikationen/211015_StAR_Teil_III_DE_MDRO_Outbreak_fin.pdf
  26. Senn L, Vuichard-Gysin D, Tschudin-Sutter S, Harbarth S, Büchler AC, National Nosocomial Outbreak Investigation Center Swissnoso. Update bezüglich des Aufkommens und der raschen interregionalen Verbreitung von Vancomycin-resistenten Enterococcus faecium (VRE) vanA ST612 in der Schweiz. [Update regarding the emergence and rapid interregional spread of vancomycin-resistant Enterococcus faecium (VRE) vanA ST612 in Switzerland]. Bern: Swissnoso; 2024. German. Available from: https://swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Ereignisse/240531_Swissnoso_Update_VRE_vanA_ST612_DE.pdf
  27. Senn L, Vuichard Gysin D, Tschudin Sutter S, Harbarth S, Büchler AC, for the National Nosocomial Outbreak Investigation Center. Abschliessende Stellungnahme und Empfehlungen bezüglich der interregionalen Verbreitung von Vancomycin-resistenten Enterococcus faecium (VRE) vanA ST612 in der Schweiz. [Final statement and recommendations regarding the emergence and rapid interregional spread of vancomycin-resistant Enterococcus faecium (VRE) vanA ST612 in Switzerland]. Bern: Swissnoso; 2025. German. Available from: https://swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Ereignisse/250120_Swissnoso_Update_VRE_vanA_ST612_DE.pdf
  28. Buetti N, Wassilew N, Rion V, Senn L, Gardiol C, Widmer A, et al. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey. Antimicrob Resist Infect Control. 2019;8(1):16.  https://doi.org/10.1186/s13756-019-0466-x  PMID: 30675343 
  29. Willems RPJ, van Dijk K, Vehreschild MJGT, Biehl LM, Ket JCF, Remmelzwaal S, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis. 2023;23(6):719-31.  https://doi.org/10.1016/S1473-3099(22)00811-8  PMID: 36731484 
  30. Vuichard-Gysin D, Sommerstein R, Kronenberg A, Buetti N, Eder M, Piezzi V, et al. High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey. Antimicrob Resist Infect Control. 2022;11(1):19.  https://doi.org/10.1186/s13756-022-01051-9  PMID: 35090563 
  31. Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, et al. Influence of minimum inhibitory concentration in clinical outcomes of Enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint? Clin Infect Dis. 2016;62(12):1514-20.  https://doi.org/10.1093/cid/ciw173  PMID: 27045126 
  32. Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, et al. clinical outcomes of daptomycin for vancomycin-resistant Enterococcus bacteremia. Clin Ther. 2015;37(7):1443-1453.e2.  https://doi.org/10.1016/j.clinthera.2015.04.008  PMID: 25982687 
  33. Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS. Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother. 2011;55(7):3345-56.  https://doi.org/10.1128/AAC.00207-11  PMID: 21502617 
  34. Egli A, Schmid H, Kuenzli E, Widmer AF, Battegay M, Plagge H, et al. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis. Clin Microbiol Infect. 2017;23(2):118.e1-7.  https://doi.org/10.1016/j.cmi.2016.10.003  PMID: 27746397 
  35. Kinnear CL, Hansen E, Morley VJ, Tracy KC, Forstchen M, Read AF, et al. Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium. PLoS Biol. 2020;18(12):e3000987.  https://doi.org/10.1371/journal.pbio.3000987  PMID: 33332354 
  36. Prater AG, Mehta HH, Kosgei AJ, Miller WR, Tran TT, Arias CA, et al. Environment shapes the accessible daptomycin resistance mechanisms in Enterococcus faecium. Antimicrob Agents Chemother. 2019;63(10):e00790-19.  https://doi.org/10.1128/AAC.00790-19  PMID: 31332078 
  37. Marciniak T, Kirchner L, Wolf SA, Walther B, Bischler T, Nyasinga J, et al. Emergence of transferable daptomycin resistance in Gram-positive bacteria. NPJ Antimicrob Resist. 2025;3(33).  https://doi.org/10.1128/AAC.00790-19  PMID: 31332078 
  38. Bayjanov JR, Baan J, Rogers MRC, Troelstra A, Willems RJL, van Schaik W. Enterococcus faecium genome dynamics during long-term asymptomatic patient gut colonization. Microb Genom. 2019;5(7):e000277.  https://doi.org/10.1099/mgen.0.000277  PMID: 31166888 
  39. El Haddad L, Hanson BM, Arias CA, Ghantoji SS, Harb CP, Stibich M, et al. Emergence and transmission of daptomycin and vancomycin-resistant Enterococci between patients and hospital rooms. Clin Infect Dis. 2021;73(12):2306-13.  https://doi.org/10.1093/cid/ciab001  PMID: 33421068 
  40. Satlin MJ, Nicolau DP, Humphries RM, Kuti JL, Campeau SA, Lewis Ii JS, et al. Development of daptomycin susceptibility breakpoints for Enterococcus faecium and revision of the breakpoints for other Enterococcal species by the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2020;70(6):1240-6.  https://doi.org/10.1093/cid/ciz845  PMID: 31504338 
  41. Wassilew N, Seth-Smith HM, Rolli E, Fietze Y, Casanova C, Führer U, et al. Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018. Euro Surveill. 2018;23(29):1800351.  https://doi.org/10.2807/1560-7917.ES.2018.23.29.1800351  PMID: 30043725 
  42. Piezzi V, Wassilew N, Atkinson A, D’Incau S, Kaspar T, Seth-Smith HMB, et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, Switzerland, 2017 to 2020. Euro Surveill. 2022;27(48):2200285.  https://doi.org/10.2807/1560-7917.ES.2022.27.48.2200285  PMID: 36695463 
  43. Higgs C, Sherry NL, Seemann T, Horan K, Walpola H, Kinsella P, et al. Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings. Nat Commun. 2022;13(1):509.  https://doi.org/10.1038/s41467-022-28156-4  PMID: 35082278 
  44. de Been M, Pinholt M, Top J, Bletz S, Mellmann A, van Schaik W, et al. Core genome multilocus sequence typing scheme for high-resolution typing of enterococcus faecium. J Clin Microbiol. 2015;53(12):3788-97.  https://doi.org/10.1128/JCM.01946-15  PMID: 26400782 
  45. Knudsen MJS, Rubin IMC, Gisselø K, Mollerup S, Petersen AM, Pinholt M, et al. The use of core genome multilocus sequence typing to determine the duration of vancomycin-resistant Enterococcus faecium outbreaks. APMIS. 2022;130(6):323-9.  https://doi.org/10.1111/apm.13216  PMID: 35253272 
  46. Zhou X, Chlebowicz MA, Bathoorn E, Rosema S, Couto N, Lokate M, et al. Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements. J Antimicrob Chemother. 2018;73(12):3259-67.  https://doi.org/10.1093/jac/dky349  PMID: 30219855 
  47. Weterings V, van Oosten A, Nieuwkoop E, Nelson J, Voss A, Wintermans B, et al. Management of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014-2017: successful control using a restrictive screening strategy. Antimicrob Resist Infect Control. 2021;10(1):38.  https://doi.org/10.1186/s13756-021-00906-x  PMID: 33602300 
  48. Raven KE, Gouliouris T, Brodrick H, Coll F, Brown NM, Reynolds R, et al. Complex routes of nosocomial vancomycin-resistant Enterococcus faecium transmission revealed by genome sequencing. Clin Infect Dis. 2017;64(7):886-93.  https://doi.org/10.1093/cid/ciw872  PMID: 28362945 
  49. Pinholt M, Larner-Svensson H, Littauer P, Moser CE, Pedersen M, Lemming LE, et al. Multiple hospital outbreaks of vanA Enterococcus faecium in Denmark, 2012-13, investigated by WGS, MLST and PFGE. J Antimicrob Chemother. 2015;70(9):2474-82.  https://doi.org/10.1093/jac/dkv142  PMID: 26031466 
Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Danielle+Vuichard-Gysin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vuichard-Gysin Danielle</a>, <a href="/search?value1=Andrea+C+B%C3%BCchler&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Büchler Andrea C</a>, <a href="/search?value1=Dominique+S+Blanc&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Blanc Dominique S</a>, <a href="/search?value1=Peter+M+Keller&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Keller Peter M</a>, <a href="/search?value1=Pascal+Schl%C3%A4pfer&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schläpfer Pascal</a>, <a href="/search?value1=Andreas+Kronenberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kronenberg Andreas</a>, <a href="/search?value1=Vanja+Piezzi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Piezzi Vanja</a>, <a href="/search?value1=Patrice+Nordmann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Nordmann Patrice</a>, <a href="/search?value1=Laurence+Senn&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Senn Laurence</a>, <a href="/search?value1=Stephan+Harbarth&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Harbarth Stephan</a>, <a href="/search?value1=Sarah+Tschudin-Sutter&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tschudin-Sutter Sarah</a></span>. Emergence of vancomycin-resistant Enterococcus faecium vanA ST612 with reduced daptomycin susceptibility, Switzerland, 2018 to 2024. <a href="/content/ecdc">Euro Surveill.</a> 2025;30(45):pii=2500227. <a href="https://doi.org/10.2807/1560-7917.ES.2025.30.45.2500227" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2025.30.45.2500227</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 30 Mar 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 17 Jul 2025 </span> </p>
/content/10.2807/1560-7917.ES.2025.30.45.2500227
/content/10.2807/1560-7917.ES.2025.30.45.2500227
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error